Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

4P-Pharma (FR)

4P-Pharma is a company focusing on preclinical research and specializing in the development of new, innovative and first-in-class medical drugs and therapeutic agents, that meet unfulfilled medical needs in the fields of oncology and inflammatory diseases and notably for therapeutic indications of rare diseases. The activity of 4P-Pharma is based on acquiring licensing options for innovative technologies at an early stage of development in the biomedical field, following the detection and the assessment of innovative projects derived from academic laboratories and Universities, from French SATTs (Technology Transfer Acceleration Companies), from technology transfer offices as well as from start- ups and firms in the pharmaceutical and biotechnology sector. 4P-Pharma defines and implements a co-development maturation project with the partner that is the owner of the rights, so as to speed up technology development time and reduce the risks connected with the initial validation phases. If the outcome of the maturation program is positive, 4P Pharma exercises a licensing option for the developed technologies and implements regulatory preclinical development until phase I/IIa is reached. *


Period Start 2015-09-16 existent
Product Industry drug development services
Person Person Rattenbach, Revital (4P-Pharma 201609 CEO)
Region Region Lille
  Country France
  Street 1 Rue du Professeur Calmette
  City 59000 Lille
  Tel +33-9-5072-9768
    Address record changed: 2016-09-04
    * Document for �About Section�: 4P-Pharma. (9/1/16). "Press Release: Signature of a License Agreement with 4P-Pharma for the Development of an Anti-cancer Drug". Talence.
Record changed: 2018-09-12


Picture [LSUS] – The Business Web Portal 650x112px

More documents for 4P-Pharma (FR)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top